Patents by Inventor Bijia Deng

Bijia Deng has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Type 2 cytokine receptor and nucleic acids encoding same
    Publication number: 20070196370
    Abstract: The present invention provides novel isolated CRF2-12 polynucleotides and polypeptides encoded by the CRF2-12 polynucleotides. Also provided are the antibodies that immunospecifically bind to a CRF2-12 polypeptide or any derivative (including fusion derivative), variant, mutant or fragment of the CRF2-12 polypeptide, polynucleotide or antibody. The invention additionally provides methods in which the CRF2-12 polypeptide, polynucleotide and antibody are utilized in the detection and treatment of a broad range of pathological states, as well as to other uses.
    Type: Application
    Filed: January 11, 2007
    Publication date: August 23, 2007
    Inventors: Lynette Fouser, Wei Liu, Bijia Deng
  • Type 2 cytokine receptor and nucleic acids encoding same
    Patent number: 7176180
    Abstract: The present invention provides novel isolated CRF2-12 polynucleotides and polypeptides encoded by the CRF2-12 polynucleotides. Also provided are the antibodies that immunospecifically bind to a CRF2-12 polypeptide or any derivative (including fusion derivative), variant, mutant or fragment of the CRF2-12 polypeptide, polynucleotide or antibody. The invention additionally provides methods in which the CRF2-12 polypeptide, polynucleotide and antibody are utilized in the detection and treatment of a broad range of pathological states, as well as to other uses.
    Type: Grant
    Filed: January 14, 2002
    Date of Patent: February 13, 2007
    Assignee: Wyeth
    Inventors: Lynette Fouser, Wei Liu, Bijia Deng
  • Type 2 cytokine receptor and nucleic acids encoding same
    Publication number: 20030170839
    Abstract: The present invention provides novel isolated CRF2-12 polynucleotides and polypeptides encoded by the CRF2-12 polynucleotides. Also provided are the antibodies that immunospecifically bind to a CRF2-12 polypeptide or any derivative (including fusion derivative), variant, mutant or fragment of the CRF2-12 polypeptide, polynucleotide or antibody. The invention additionally provides methods in which the CRF2-12 polypeptide, polynucleotide and antibody are utilized in the detection and treatment of a broad range of pathological states, as well as to other uses.
    Type: Application
    Filed: January 14, 2002
    Publication date: September 11, 2003
    Inventors: Lynette Fouser, Wei Liu, Bijia Deng